Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy.
Saved in:
| Title: | Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy. |
|---|---|
| Authors: | Burke AM; Department of Radiation Oncology, Brody School of Medicine, East Carolina University, Greenville, NC, United States., Carrasquilla M; Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC, United States., Jean WC; George Washington University Hospital, Washington, DC, United States., Collins BT; Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC, United States., Anaizi AN; Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, DC, United States., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States., Gibney GT; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States., Collins SP; Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Jan 12; Vol. 11, pp. 794615. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2021.794615 |
